GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3)

 AF9_HUMAN               Reviewed;         568 AA.
P42568; B1AMQ2; B2R7B3; B7Z755; D3DRJ8; Q8IVB0;
01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
25-NOV-2008, sequence version 2.
31-JUL-2019, entry version 167.
RecName: Full=Protein AF-9;
AltName: Full=ALL1-fused gene from chromosome 9 protein;
AltName: Full=Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein;
AltName: Full=YEATS domain-containing protein 3;
Name=MLLT3 {ECO:0000312|HGNC:HGNC:7136}; Synonyms=AF9, YEATS3;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
WITH KMT2A.
PubMed=8506309; DOI=10.1073/pnas.90.10.4631;
Nakamura T., Alder H., Gu Y., Prasad R., Canaani O., Kamada N.,
Gale R.P., Lange B., Crist W.M., Nowell P.C., Croce C.M., Canaani E.;
"Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in
acute leukemia share sequence homology and/or common motifs.";
Proc. Natl. Acad. Sci. U.S.A. 90:4631-4635(1993).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
TISSUE=Brain, and Synovium;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15164053; DOI=10.1038/nature02465;
Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
Rogers J., Dunham I.;
"DNA sequence and analysis of human chromosome 9.";
Nature 429:369-374(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Testis;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
INTERACTION WITH BCOR.
PubMed=10898795;
Huynh K.D., Fischle W., Verdin E., Bardwell V.J.;
"BCoR, a novel corepressor involved in BCL-6 repression.";
Genes Dev. 14:1810-1823(2000).
[7]
CHROMOSOMAL TRANSLOCATION.
PubMed=10861294;
Strissel P.L., Strick R., Tomek R.J., Roe B.A., Rowley J.D.,
Zeleznik-Le N.J.;
"DNA structural properties of AF9 are similar to MLL and could act as
recombination hot spots resulting in MLL/AF9 translocations and
leukemogenesis.";
Hum. Mol. Genet. 9:1671-1679(2000).
[8]
INTERACTION WITH CBX8.
PubMed=11313972; DOI=10.1038/sj.onc.1204108;
Garcia-Cuellar M.P., Zilles O., Schreiner S.A., Birke M.,
Winkler T.H., Slany R.K.;
"The ENL moiety of the childhood leukemia-associated MLL-ENL
oncoprotein recruits human Polycomb 3.";
Oncogene 20:411-419(2001).
[9]
CHROMOSOMAL TRANSLOCATION.
PubMed=16001262; DOI=10.1007/s00439-005-0004-1;
Pramparo T., Grosso S., Messa J., Zatterale A., Bonaglia M.C.,
Chessa L., Balestri P., Rocchi M., Zuffardi O., Giorda R.;
"Loss-of-function mutation of the AF9/MLLT3 gene in a girl with
neuromotor development delay, cerebellar ataxia, and epilepsy.";
Hum. Genet. 118:76-81(2005).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294 AND SER-483, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
Greff Z., Keri G., Stemmann O., Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of
the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
[11]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-288; SER-294 AND
SER-483, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[12]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
Mann M., Daub H.;
"Large-scale proteomics analysis of the human kinome.";
Mol. Cell. Proteomics 8:1751-1764(2009).
[13]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412 AND SER-419, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Leukemic T-cell;
PubMed=19690332; DOI=10.1126/scisignal.2000007;
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
Rodionov V., Han D.K.;
"Quantitative phosphoproteomic analysis of T cell receptor signaling
reveals system-wide modulation of protein-protein interactions.";
Sci. Signal. 2:RA46-RA46(2009).
[14]
FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
PubMed=20471948; DOI=10.1016/j.molcel.2010.04.013;
He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J.,
Alber T., Zhou Q.;
"HIV-1 Tat and host AFF4 recruit two transcription elongation factors
into a bifunctional complex for coordinated activation of HIV-1
transcription.";
Mol. Cell 38:428-438(2010).
[15]
FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
PubMed=20159561; DOI=10.1016/j.molcel.2010.01.026;
Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S.,
Florens L., Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A.;
"AFF4, a component of the ELL/P-TEFb elongation complex and a shared
subunit of MLL chimeras, can link transcription elongation to
leukemia.";
Mol. Cell 37:429-437(2010).
[16]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=20068231; DOI=10.1126/scisignal.2000475;
Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
Mann M.;
"Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis.";
Sci. Signal. 3:RA3-RA3(2010).
[17]
IDENTIFICATION IN THE SEC COMPLEX.
PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L.,
Washburn M.P., Eissenberg J.C., Shilatifard A.;
"The little elongation complex regulates small nuclear RNA
transcription.";
Mol. Cell 44:954-965(2011).
[18]
REVIEW ON THE SUPER ELONGATION COMPLEX.
PubMed=22895430; DOI=10.1038/nrm3417;
Luo Z., Lin C., Shilatifard A.;
"The super elongation complex (SEC) family in transcriptional
control.";
Nat. Rev. Mol. Cell Biol. 13:543-547(2012).
[19]
INTERACTION WITH ALKBH4.
PubMed=23145062; DOI=10.1371/journal.pone.0049045;
Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M.,
Meza-Zepeda L.A., Falnes P.O.;
"Human ALKBH4 interacts with proteins associated with transcription.";
PLoS ONE 7:E49045-E49045(2012).
[20]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294 AND SER-483, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[21]
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339, AND IDENTIFICATION BY
MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=25218447; DOI=10.1038/nsmb.2890;
Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
Vertegaal A.C.;
"Uncovering global SUMOylation signaling networks in a site-specific
manner.";
Nat. Struct. Mol. Biol. 21:927-936(2014).
[22]
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339, AND IDENTIFICATION BY
MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=28112733; DOI=10.1038/nsmb.3366;
Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
Nielsen M.L.;
"Site-specific mapping of the human SUMO proteome reveals co-
modification with phosphorylation.";
Nat. Struct. Mol. Biol. 24:325-336(2017).
[23]
STRUCTURE BY NMR OF 490-568 IN COMPLEX WITH AFF1.
PubMed=23260655; DOI=10.1016/j.str.2012.11.011;
Leach B.I., Kuntimaddi A., Schmidt C.R., Cierpicki T., Johnson S.A.,
Bushweller J.H.;
"Leukemia fusion target AF9 is an intrinsically disordered
transcriptional regulator that recruits multiple partners via coupled
folding and binding.";
Structure 21:176-183(2013).
[24]
X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-138 IN COMPLEX WITH H3K9AC
PEPTIDE, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF
PHE-28; HIS-56; SER-58; PHE-59; GLY-77; TYR-78; PHE-81 AND ASP-103.
PubMed=25417107; DOI=10.1016/j.cell.2014.09.049;
Li Y., Wen H., Xi Y., Tanaka K., Wang H., Peng D., Ren Y., Jin Q.,
Dent S.Y., Li W., Li H., Shi X.;
"AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79
methylation.";
Cell 159:558-571(2014).
[25]
X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 1-138 IN COMPLEX WITH H3K9CR
PEPTIDE, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF
PHE-28; HIS-56; SER-58; PHE-59; GLY-77 AND TYR-78.
PubMed=27105114; DOI=10.1016/j.molcel.2016.03.028;
Li Y., Sabari B.R., Panchenko T., Wen H., Zhao D., Guan H., Wan L.,
Huang H., Tang Z., Zhao Y., Roeder R.G., Shi X., Allis C.D., Li H.;
"Molecular coupling of histone crotonylation and active transcription
by AF9 YEATS domain.";
Mol. Cell 62:181-193(2016).
[26]
STRUCTURE BY NMR OF 1-138, FUNCTION, DOMAIN, AND MUTAGENESIS OF PHE-59
AND TYR-78.
PubMed=27545619; DOI=10.1016/j.str.2016.05.023;
Zhang Q., Zeng L., Zhao C., Ju Y., Konuma T., Zhou M.M.;
"Structural insights into histone crotonyl-lysine recognition by the
AF9 YEATS domain.";
Structure 24:1606-1612(2016).
-!- FUNCTION: Chromatin reader component of the super elongation
complex (SEC), a complex required to increase the catalytic rate
of RNA polymerase II transcription by suppressing transient
pausing by the polymerase at multiple sites along the DNA
(PubMed:20159561, PubMed:20471948, PubMed:25417107,
PubMed:27105114, PubMed:27545619). Specifically recognizes and
binds acylated histone H3, with a marked preference for histone H3
that is crotonylated (PubMed:25417107, PubMed:27105114,
PubMed:27545619). Crotonylation marks active promoters and
enhancers and confers resistance to transcriptional repressors
(PubMed:25417107, PubMed:27105114, PubMed:27545619). Recognizes
and binds histone H3 crotonylated at 'Lys-9' (H3K9cr), and with
slightly lower affinity histone H3 crotonylated at 'Lys-18'
(H3K18cr) (PubMed:27105114). Also recognizes and binds histone H3
acetylated at 'Lys-9' (H3K9ac), but with lower affinity than
crotonylated histone H3 (PubMed:25417107, PubMed:27105114). In the
SEC complex, MLLT3 is required to recruit the complex to
crotonylated histones (PubMed:27105114, PubMed:27545619).
{ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948,
ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114,
ECO:0000269|PubMed:27545619}.
-!- SUBUNIT: Component of the super elongation complex (SEC), at least
composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the
P-TEFb complex and ELL (ELL, ELL2 or ELL3) (PubMed:20159561,
PubMed:20471948, PubMed:22195968, PubMed:23260655,
PubMed:25417107). Interacts with BCOR (PubMed:10898795). Interacts
with CBX8 (PubMed:11313972). Interacts with ALKBH4
(PubMed:23145062). {ECO:0000269|PubMed:10898795,
ECO:0000269|PubMed:11313972, ECO:0000269|PubMed:20159561,
ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968,
ECO:0000269|PubMed:23145062, ECO:0000269|PubMed:23260655,
ECO:0000269|PubMed:25417107}.
-!- INTERACTION:
P51825:AFF1; NbExp=7; IntAct=EBI-716132, EBI-2610180;
Q9UHB7:AFF4; NbExp=4; IntAct=EBI-716132, EBI-395282;
Q9NXW9:ALKBH4; NbExp=4; IntAct=EBI-716132, EBI-8637516;
Q92624:APPBP2; NbExp=3; IntAct=EBI-716132, EBI-743771;
Q6W2J9-1:BCOR; NbExp=2; IntAct=EBI-716132, EBI-16028932;
Q9HC52:CBX8; NbExp=2; IntAct=EBI-716132, EBI-712912;
Q8TEK3:DOT1L; NbExp=6; IntAct=EBI-716132, EBI-2619253;
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
ProRule:PRU00376, ECO:0000269|PubMed:27105114}. Chromosome
{ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114}.
Note=Colocalizes with acylated histone H3 (PubMed:25417107,
PubMed:27105114). Colocalizes with histone H3 crotonylated at
'Lys-18' (H3K18cr) (PubMed:27105114).
{ECO:0000269|PubMed:25417107, ECO:0000269|PubMed:27105114}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=P42568-1; Sequence=Displayed;
Name=2;
IsoId=P42568-2; Sequence=VSP_054924;
Note=No experimental confirmation available.;
-!- DOMAIN: The YEATS domain specifically recognizes and binds
acylated histones, with a marked preference histones that are
crotonylated (PubMed:27105114, PubMed:27545619). Also binds
histone H3 acetylated at 'Lys-9' (H3K9ac), but with lower affinity
(PubMed:25417107, PubMed:27105114). {ECO:0000269|PubMed:25417107,
ECO:0000269|PubMed:27105114, ECO:0000269|PubMed:27545619}.
-!- DISEASE: Note=A chromosomal aberration involving MLLT3 is
associated with acute leukemias. Translocation t(9;11)(p22;q23)
with KMT2A/MLL1. The result is a rogue activator protein.
{ECO:0000269|PubMed:10861294, ECO:0000269|PubMed:8506309}.
-!- DISEASE: Note=A chromosomal aberration involving MLLT3 was
observed in a patient with neuromotor development delay,
cerebellar ataxia and epilepsy. Translocation t(4;9)(q35;p22).
{ECO:0000269|PubMed:16001262}.
-!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
and Haematology;
URL="http://atlasgeneticsoncology.org/Genes/AF9ID5.html";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; L13744; AAA58361.1; -; mRNA.
EMBL; AK301474; BAH13491.1; -; mRNA.
EMBL; AK312914; BAG35760.1; -; mRNA.
EMBL; AL354879; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL512635; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL513498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL163193; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL627410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471071; EAW58631.1; -; Genomic_DNA.
EMBL; CH471071; EAW58632.1; -; Genomic_DNA.
EMBL; BC036089; AAH36089.1; -; mRNA.
CCDS; CCDS6494.1; -. [P42568-1]
CCDS; CCDS69579.1; -. [P42568-2]
PIR; I39411; I39411.
RefSeq; NP_001273620.1; NM_001286691.1. [P42568-2]
RefSeq; NP_004520.2; NM_004529.3. [P42568-1]
PDB; 2LM0; NMR; -; A=490-568.
PDB; 2MV7; NMR; -; A=500-568.
PDB; 2N4Q; NMR; -; B=500-568.
PDB; 2NDF; NMR; -; A=1-138.
PDB; 2NDG; NMR; -; A=1-138.
PDB; 4TMP; X-ray; 2.30 A; A/C=1-138.
PDB; 5HJB; X-ray; 2.70 A; A=1-138.
PDB; 5HJD; X-ray; 2.81 A; A/C/E/G/K/N/Q/T=1-138.
PDB; 5YYF; X-ray; 1.90 A; A/C=1-138.
PDB; 6B7G; NMR; -; A=500-568.
PDB; 6MIL; X-ray; 1.93 A; A/C=1-138.
PDB; 6MIM; X-ray; 2.52 A; A/C=1-138.
PDBsum; 2LM0; -.
PDBsum; 2MV7; -.
PDBsum; 2N4Q; -.
PDBsum; 2NDF; -.
PDBsum; 2NDG; -.
PDBsum; 4TMP; -.
PDBsum; 5HJB; -.
PDBsum; 5HJD; -.
PDBsum; 5YYF; -.
PDBsum; 6B7G; -.
PDBsum; 6MIL; -.
PDBsum; 6MIM; -.
SMR; P42568; -.
BioGrid; 110446; 65.
CORUM; P42568; -.
DIP; DIP-56409N; -.
IntAct; P42568; 37.
STRING; 9606.ENSP00000369695; -.
iPTMnet; P42568; -.
PhosphoSitePlus; P42568; -.
BioMuta; MLLT3; -.
DMDM; 215273971; -.
jPOST; P42568; -.
MaxQB; P42568; -.
PaxDb; P42568; -.
PeptideAtlas; P42568; -.
PRIDE; P42568; -.
ProteomicsDB; 55517; -. [P42568-1]
ProteomicsDB; 6833; -.
Ensembl; ENST00000380338; ENSP00000369695; ENSG00000171843. [P42568-1]
Ensembl; ENST00000630269; ENSP00000485996; ENSG00000171843. [P42568-2]
GeneID; 4300; -.
KEGG; hsa:4300; -.
UCSC; uc003zoe.3; human. [P42568-1]
CTD; 4300; -.
DisGeNET; 4300; -.
GeneCards; MLLT3; -.
HGNC; HGNC:7136; MLLT3.
HPA; HPA001824; -.
MalaCards; MLLT3; -.
MIM; 159558; gene.
neXtProt; NX_P42568; -.
OpenTargets; ENSG00000171843; -.
Orphanet; 402017; Acute myeloid leukemia with t(9;11)(p22;q23).
PharmGKB; PA30852; -.
eggNOG; KOG3149; Eukaryota.
eggNOG; COG5033; LUCA.
GeneTree; ENSGT00940000155903; -.
InParanoid; P42568; -.
KO; K15187; -.
OMA; PNRSVHT; -.
OrthoDB; 727038at2759; -.
PhylomeDB; P42568; -.
TreeFam; TF314586; -.
Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
SIGNOR; P42568; -.
ChiTaRS; MLLT3; human.
GeneWiki; MLLT3; -.
GenomeRNAi; 4300; -.
PRO; PR:P42568; -.
Proteomes; UP000005640; Chromosome 9.
Bgee; ENSG00000171843; Expressed in 193 organ(s), highest expression level in frontal cortex.
ExpressionAtlas; P42568; baseline and differential.
Genevisible; P42568; HS.
GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
GO; GO:0005634; C:nucleus; TAS:ProtInc.
GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
GO; GO:0042393; F:histone binding; IDA:UniProtKB.
GO; GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB.
GO; GO:0140030; F:modification-dependent protein binding; IDA:UniProtKB.
GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:MGI.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
GO; GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IGI:MGI.
GO; GO:0007379; P:segment specification; IEA:Ensembl.
GO; GO:0006366; P:transcription by RNA polymerase II; TAS:Reactome.
GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DisProt; DP01070; -.
Gene3D; 2.60.40.1970; -; 1.
InterPro; IPR040930; AF-9_AHD.
InterPro; IPR038704; YEAST_sf.
InterPro; IPR005033; YEATS.
PANTHER; PTHR23195; PTHR23195; 1.
Pfam; PF17793; AHD; 1.
Pfam; PF03366; YEATS; 1.
PROSITE; PS51037; YEATS; 1.
1: Evidence at protein level;
3D-structure; Activator; Alternative splicing;
Chromosomal rearrangement; Chromosome; Complete proteome;
Isopeptide bond; Nucleus; Phosphoprotein; Proto-oncogene;
Reference proteome; Transcription; Transcription regulation;
Ubl conjugation.
CHAIN 1 568 Protein AF-9.
/FTId=PRO_0000215921.
DOMAIN 8 112 YEATS. {ECO:0000255|PROSITE-
ProRule:PRU00376}.
REGION 78 80 Histone H3K9cr binding.
{ECO:0000244|PDB:5HJB,
ECO:0000244|PDB:5HJD,
ECO:0000269|PubMed:27105114}.
REGION 106 108 Histone H3K9cr binding.
{ECO:0000244|PDB:5HJB,
ECO:0000244|PDB:5HJD,
ECO:0000269|PubMed:27105114}.
MOTIF 295 300 Nuclear localization signal.
{ECO:0000255}.
COMPBIAS 149 194 Poly-Ser.
COMPBIAS 383 391 Poly-Ser.
COMPBIAS 466 469 Poly-Pro.
BINDING 58 58 Histone H3K9cr. {ECO:0000244|PDB:5HJB,
ECO:0000244|PDB:5HJD,
ECO:0000269|PubMed:27105114}.
BINDING 103 103 Histone H3K9cr. {ECO:0000244|PDB:5HJB,
ECO:0000244|PDB:5HJD,
ECO:0000269|PubMed:27105114}.
SITE 375 375 KMT2A/MLL1 fusion point (in acute myeloid
leukemia patient CO).
{ECO:0000269|PubMed:8506309}.
SITE 481 481 KMT2A/MLL1 fusion point (in acute myeloid
leukemia patient F1).
{ECO:0000269|PubMed:8506309}.
MOD_RES 288 288 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 294 294 Phosphoserine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:18691976,
ECO:0000244|PubMed:23186163}.
MOD_RES 412 412 Phosphoserine.
{ECO:0000244|PubMed:19690332}.
MOD_RES 419 419 Phosphoserine.
{ECO:0000244|PubMed:19690332}.
MOD_RES 483 483 Phosphoserine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:18691976,
ECO:0000244|PubMed:20068231,
ECO:0000244|PubMed:23186163}.
CROSSLNK 339 339 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:25218447,
ECO:0000244|PubMed:28112733}.
VAR_SEQ 1 4 MASS -> M (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_054924.
MUTAGEN 28 28 F->A: Decreased binding to crotonylated
histone H3. Decreased binding to
acetylated histone H3.
{ECO:0000269|PubMed:25417107,
ECO:0000269|PubMed:27105114}.
MUTAGEN 56 56 H->A: Decreased binding to crotonylated
histone H3. Decreased binding to
acetylated histone H3.
{ECO:0000269|PubMed:25417107,
ECO:0000269|PubMed:27105114}.
MUTAGEN 58 58 S->A: Decreased binding to crotonylated
histone H3. Decreased binding to
acetylated histone H3.
{ECO:0000269|PubMed:25417107,
ECO:0000269|PubMed:27105114}.
MUTAGEN 59 59 F->A: Strongly decreased binding to
crotonylated histone H3. Decreased
binding to acetylated histone H3.
{ECO:0000269|PubMed:25417107,
ECO:0000269|PubMed:27105114,
ECO:0000269|PubMed:27545619}.
MUTAGEN 77 77 G->A: Decreased binding to crotonylated
histone H3. Decreased binding to
acetylated histone H3.
{ECO:0000269|PubMed:25417107,
ECO:0000269|PubMed:27105114}.
MUTAGEN 78 78 Y->A: Strongly decreased binding to
crotonylated histone H3. Decreased
binding to acetylated histone H3.
{ECO:0000269|PubMed:25417107,
ECO:0000269|PubMed:27105114,
ECO:0000269|PubMed:27545619}.
MUTAGEN 81 81 F->A: Decreased binding to acetylated
histone H3.
{ECO:0000269|PubMed:25417107}.
MUTAGEN 103 103 D->A: Decreased binding to acetylated
histone H3.
{ECO:0000269|PubMed:25417107}.
CONFLICT 6 6 A -> S (in Ref. 1; AAA58361 and 2;
BAG35760). {ECO:0000305}.
CONFLICT 173 173 S -> G (in Ref. 5; AAH36089).
{ECO:0000305}.
CONFLICT 419 419 S -> P (in Ref. 2; BAG35760).
{ECO:0000305}.
STRAND 6 19 {ECO:0000244|PDB:5YYF}.
STRAND 30 37 {ECO:0000244|PDB:5YYF}.
HELIX 39 41 {ECO:0000244|PDB:5YYF}.
TURN 45 47 {ECO:0000244|PDB:5YYF}.
STRAND 48 54 {ECO:0000244|PDB:5YYF}.
STRAND 59 61 {ECO:0000244|PDB:5YYF}.
STRAND 63 90 {ECO:0000244|PDB:5YYF}.
STRAND 92 94 {ECO:0000244|PDB:5YYF}.
STRAND 97 104 {ECO:0000244|PDB:5YYF}.
STRAND 114 126 {ECO:0000244|PDB:5YYF}.
HELIX 129 135 {ECO:0000244|PDB:5YYF}.
HELIX 504 515 {ECO:0000244|PDB:2LM0}.
HELIX 523 531 {ECO:0000244|PDB:2LM0}.
STRAND 536 538 {ECO:0000244|PDB:2LM0}.
STRAND 543 545 {ECO:0000244|PDB:2LM0}.
TURN 547 549 {ECO:0000244|PDB:2LM0}.
HELIX 552 561 {ECO:0000244|PDB:2LM0}.
SEQUENCE 568 AA; 63351 MW; 0A020B7FB34132F9 CRC64;
MASSCAVQVK LELGHRAQVR KKPTVEGFTH DWMVFVRGPE HSNIQHFVEK VVFHLHESFP
RPKRVCKDPP YKVEESGYAG FILPIEVYFK NKEEPRKVRF DYDLFLHLEG HPPVNHLRCE
KLTFNNPTED FRRKLLKAGG DPNRSIHTSS SSSSSSSSSS SSSSSSSSSS SSSSSSSSSS
SSSSSSSSSS TSFSKPHKLM KEHKEKPSKD SREHKSAFKE PSRDHNKSSK ESSKKPKENK
PLKEEKIVPK MAFKEPKPMS KEPKPDSNLL TITSGQDKKA PSKRPPISDS EELSAKKRKK
SSSEALFKSF SSAPPLILTC SADKKQIKDK SHVKMGKVKI ESETSEKKKS TLPPFDDIVD
PNDSDVEENI SSKSDSEQPS PASSSSSSSS SFTPSQTRQQ GPLRSIMKDL HSDDNEEESD
EVEDNDNDSE MERPVNRGGS RSRRVSLSDG SDSESSSASS PLHHEPPPPL LKTNNNQILE
VKSPIKQSKS DKQIKNGECD KAYLDELVEL HRRLMTLRER HILQQIVNLI EETGHFHITN
TTFDFDLCSL DKTTVRKLQS YLETSGTS


Related products :

Catalog number Product name Quantity
EIAAB05366 AF15q14,ALL1-fused gene from chromosome 15q14 protein,Blinkin,Bub-linking kinetochore protein,Cancer susceptibility candidate gene 5 protein,Cancer_testis antigen 29,CASC5,CT29,Homo sapiens,Human,KIAA
GWB-92F5DD Anti- MLLT4 (myeloid lymphoid or mixed-lineage leukemia; translocated to. 4) Antibody
GWB-F93000 Myeloid lymphoid Or Mixed-lineage Leukemia Translocated To 3 (MLLT3) AF9 Rabbit anti-Human Polyclonal (aa486-502) Antibody
GWB-EF7623 Myeloid lymphoid Or Mixed-lineage Leukemia (trithorax Homolog); Translocated To 2 (MLLT2) (AFF1) Rabbit anti-Human Polyclonal (
GWB-716FDD Myeloid lymphoid Or Mixed-lineage Leukemia Translocated To 4 (MLLT4) AF6 Rabbit anti-Human Polyclonal (aa1582-1597) Antibody
GWB-A343E5 Myeloid lymphoid Or Mixed-lineage Leukemia (trithorax Homolog); Translocated To 10 (MLLT10) Rabbit anti-Human Polyclonal (aa101
GWB-11F93B Myeloid lymphoid Or Mixed-lineage Leukemia Translocated To 6 (MLLT6) AF17 Rabbit anti-Human Polyclonal (aa1071-1086) Antibody
EIAAB25662 CBFA2T3,hMTG16,Homo sapiens,Human,MTG16,MTG8-related protein 2,MTGR2,Myeloid translocation gene on chromosome 16 protein,Protein CBFA2T3,Zinc finger MYND domain-containing protein 4,ZMYND4
EIAAB34097 Chronic lymphocytic leukemia deletion region gene 7 protein,CLL deletion region gene 7 protein,CLLD7,E4.5,Homo sapiens,Human,RCBTB1,RCC1 and BTB domain-containing protein 1,Regulator of chromosome con
E02M0348 Rat Myeloid lymphoid or mixed-lineage leukemia 5 ELISA 96T/kit
E02M0340 Rat Myeloid lymphoid or mixed-lineage leukemia 2 ELISA 96T/kit
E02M0332 Rat Myeloid lymphoid or mixed-lineage leukemia 3 ELISA 96T/kit
E02M0336 Rat Myeloid lymphoid or mixed-lineage leukemia 4 ELISA 96T/kit
E02M0339 Rat Myeloid lymphoid or mixed-lineage leukemia 1 ELISA 96T/kit
E09M0340 Monkey Myeloid lymphoid or mixed-lineage leukemia 2 ELISA 96T/kit
E04M0332 Rabbit Myeloid lymphoid or mixed-lineage leukemia 3 ELISA 96T/kit
E09M0348 Monkey Myeloid lymphoid or mixed-lineage leukemia 5 ELISA 96T/kit
E07M0339 Porcine Myeloid lymphoid or mixed-lineage leukemia 1 ELISA 96T/kit
E14M0339 Sheep Myeloid lymphoid or mixed-lineage leukemia 1 ELISA 96T/kit
E07M0340 Porcine Myeloid lymphoid or mixed-lineage leukemia 2 ELISA 96T/kit
E09M0339 Monkey Myeloid lymphoid or mixed-lineage leukemia 1 ELISA 96T/kit
E07M0332 Porcine Myeloid lymphoid or mixed-lineage leukemia 3 ELISA 96T/kit
E03M0348 Mouse Myeloid lymphoid or mixed-lineage leukemia 5 ELISA 96T/kit
E07M0336 Porcine Myeloid lymphoid or mixed-lineage leukemia 4 ELISA 96T/kit
E09M0332 Monkey Myeloid lymphoid or mixed-lineage leukemia 3 ELISA 96T/kit
Pathways :
WP1689: Porphyrin and chlorophyll metabolism
WP1700: Selenoamino acid metabolism
WP1049: G Protein Signaling Pathways
WP1657: Glycerolipid metabolism
WP2199: Seed Development
WP1663: Homologous recombination
WP1531: Vitamin D synthesis
WP1165: G Protein Signaling Pathways
WP1673: Naphthalene and anthracene degradation
WP232: G Protein Signaling Pathways
WP1678: Nucleotide excision repair
WP1613: 1,4-Dichlorobenzene degradation
WP1909: Signal regulatory protein (SIRP) family interactions
WP1625: Base excision repair
WP2032: TSH signaling pathway
WP813: G Protein Signaling Pathways
WP1690: Propanoate metabolism
WP1371: G Protein Signaling Pathways
WP1694: Pyrimidine metabolism
WP1654: gamma-Hexachlorocyclohexane degradation
WP211: BMP signaling pathway
WP1661: Glyoxylate and dicarboxylate metabolism
WP2218: sGC
WP1438: Influenza A virus infection
WP1714: Tyrosine metabolism

Related Genes :
[MLLT3 AF9 YEATS3] Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3)
[KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1] Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)]
[Kmt2a All1 Hrx Mll Mll1] Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)]
[KMT2D ALR MLL2 MLL4] Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)
[KMT2C HALR KIAA1506 MLL3] Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)
[Mllt3 Af9] Protein AF-9 (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein homolog)
[AFF4 AF5Q31 MCEF HSPC092] AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein)
[KNL1 CASC5 KIAA1570] Kinetochore scaffold 1 (ALL1-fused gene from chromosome 15q14 protein) (AF15q14) (Bub-linking kinetochore protein) (Blinkin) (Cancer susceptibility candidate gene 5 protein) (Cancer/testis antigen 29) (CT29) (Kinetochore-null protein 1) (Protein CASC5) (Protein D40/AF15q14)
[Kmt2d Mll2 Mll4] Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)
[AFF1 AF4 FEL MLLT2 PBM1] AF4/FMR2 family member 1 (ALL1-fused gene from chromosome 4 protein) (Protein AF-4) (Protein FEL) (Proto-oncogene AF4)
[MLLT10 AF10] Protein AF-10 (ALL1-fused gene from chromosome 10 protein)
[KMT2E MLL5] Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5)
[Kmt2c Mll3] Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog)
[Kmt2e Mll5] Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog)
[KMT2B HRX2 KIAA0304 MLL2 MLL4 TRX2 WBP7] Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)
[Kmt2b Mll2 Trx2 Wbp7] Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4 homolog) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)
[RUNX1 AML1 CBFA2] Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit)
[PICALM CALM] Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein)
[MLLT1 ENL LTG19 YEATS1] Protein ENL (YEATS domain-containing protein 1)
[TET1 CXXC6 KIAA1676 LCX] Methylcytosine dioxygenase TET1 (EC 1.14.11.n2) (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein)
[MAP3K20 MLTK ZAK HCCS4] Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)
[MCL1 BCL2L3] Induced myeloid leukemia cell differentiation protein Mcl-1 (Bcl-2-like protein 3) (Bcl2-L-3) (Bcl-2-related protein EAT/mcl1) (mcl1/EAT)
[MAP3K9 MLK1 PRKE1] Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1)
[SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069] Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)
[RUNX2 AML3 CBFA1 OSF2 PEBP2A] Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1) (CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2) (OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit) (PEA2-alpha A) (PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)
[PITX2 ARP1 RGS RIEG RIEG1] Pituitary homeobox 2 (ALL1-responsive protein ARP1) (Homeobox protein PITX2) (Paired-like homeodomain transcription factor 2) (RIEG bicoid-related homeobox transcription factor) (Solurshin)
[Pitx2 Arp1 Brx1 Otlx2 Ptx2 Rgs] Pituitary homeobox 2 (ALL1-responsive protein ARP1) (BRX1 homeoprotein) (Homeobox protein PITX2) (Orthodenticle-like homeobox 2) (Paired-like homeodomain transcription factor 2) (Paired-like homeodomain transcription factor Munc 30) (Solurshin)
[ABL1 ABL JTK7] Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)
[BCL11A CTIP1 EVI9 KIAA1809 ZNF856] B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856)
[NCKIPSD AF3P21 SPIN90] NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein) (VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1) (DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-interacting protein)

Bibliography :